Sysnav and Roche partner on movement tracking technology
Sysnav Healthcare and Roche have partnered to develop industry standard outcome measurements in diseases associated…
January 26, 2023 - 2 minutes
Neurological disorders
Funding for university to develop new motor neuron disease therapies
Medical research charity LifeArc, the Motor Neurone Disease Association (MND Association) and the My Name’5…
January 24, 2023 - 4 minutes
Team wins $149M contract for National Institute of Neurological Disorders and Stroke
A team consisting of Battelle, AmplifyBio and Andelyn Biosciences has won a seat on an…
January 12, 2023 - 3 minutes
Silo Pharma looks into the 2023 psychedelics crystal ball
Labiotech had the opportunity to ask James Kuo, vice president of R&D at Silo Pharma…
January 11, 2023 - 5 minutes
STALICLA signs agreement with Novartis on neurodevelopmental disorders
STALICLA SA, a clinical-stage biotech company advancing the first precision neurobiology platform for patients with…
January 9, 2023 - 2 minutes
Watch: IRLAB CEO Richard Godfrey
IRLAB discovers and develops novel treatments of Parkinson’s disease and other CNS disorders. The company's…
December 20, 2022 - 1 minute
Alchemab Therapeutics receives £1.7M grant to work on therapy for Huntington’s disease
Alchemab Therapeutics has been awarded a grant of £1.7 million ($2 million) from Innovate UK’s…
December 16, 2022 - 3 minutes
Charcot-Marie-Tooth study to get $250K grant
The Muscular Dystrophy Association (MDA) and Charcot-Marie-Tooth Research Foundation (CMTRF) have announced joint funding for…
December 15, 2022 - 2 minutes
EMA gives Myrtelle’s Canavan disease gene therapy candidate OD designation
Myrtelle Inc., a clinical stage gene therapy company, has announced that the European Medicines Agency…
December 15, 2022 - 3 minutes
PrecisionLife to work on R&D with Ono Pharmaceutical
PrecisionLife Limited has entered into a multi-target discovery and validation partnership with Ono Pharmaceutical Co.,…
December 14, 2022 - 2 minutes
bit.bio expands portfolio for drug discovery in neurodegenerative and neurological diseases
Cell coding company bit.bio has made three additions to its product portfolio: ioGlutamatergic Neurons MAPT…
November 30, 2022 - 3 minutes
Beyond Biotech podcast 23: World Antimicrobial Awareness Week, PsychoGenics
This week, we have three interviews on the theme of antimicrobial resistance (AMR), to mark…
November 18, 2022 - 3 minutes
